Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:BEAT

HeartBeam (BEAT) Stock Price, News & Analysis

HeartBeam logo

About HeartBeam Stock (NASDAQ:BEAT)

Advanced Chart

Key Stats

Today's Range
$2.10
$2.30
50-Day Range
$71.46
$72.27
52-Week Range
$1.17
$3.48
Volume
118,715 shs
Average Volume
104,903 shs
Market Capitalization
$41.92 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$8.00
Consensus Rating
Buy

Company Overview

HeartBeam Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
33rd Percentile Overall Score

BEAT MarketRank™: 

HeartBeam scored higher than 33% of companies evaluated by MarketBeat, and ranked 2275th out of 2,814 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    HeartBeam has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    HeartBeam has received no research coverage in the past 90 days.

  • Read more about HeartBeam's stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of HeartBeam is -1.68, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of HeartBeam is -1.68, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    HeartBeam has a P/B Ratio of 20.67. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    0.51% of the float of HeartBeam has been sold short.
  • Short Interest Ratio / Days to Cover

    HeartBeam has a short interest ratio ("days to cover") of 1.3, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in HeartBeam has recently increased by 12.20%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    HeartBeam does not currently pay a dividend.

  • Dividend Growth

    HeartBeam does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.51% of the float of HeartBeam has been sold short.
  • Short Interest Ratio / Days to Cover

    HeartBeam has a short interest ratio ("days to cover") of 1.3, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in HeartBeam has recently increased by 12.20%, indicating that investor sentiment is decreasing significantly.
  • Search Interest

    5 people have searched for BEAT on MarketBeat in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, HeartBeam insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    18.04% of the stock of HeartBeam is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 7.77% of the stock of HeartBeam is held by institutions.

  • Read more about HeartBeam's insider trading history.
Receive BEAT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for HeartBeam and its competitors with MarketBeat's FREE daily newsletter.

BEAT Stock News Headlines

IBN Coverage: HeartBeam (NASDAQ: BEAT) Is One to Watch
The End of Elon Musk…?
The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, and he's been proven right time and time again. And now, while the media focuses on Tesla's "demise," he's uncovered an AI breakthrough that's about to make Elon's doubters eat their words yet again. According to his research, if you listen to the media and miss out on Elon's newest breakthrough, it's going to cost you the fortune of a lifetime.
HeartBeam Reports First Quarter 2025 Results
See More Headlines

BEAT Stock Analysis - Frequently Asked Questions

HeartBeam, Inc. (NASDAQ:BEAT) issued its earnings results on Tuesday, May, 13th. The medical research company reported ($0.18) EPS for the quarter.
Read the conference call transcript
.

HeartBeam (BEAT) raised $16 million in an initial public offering on Thursday, November 11th 2021. The company issued 2,750,000 shares at a price of $5.50-$6.50 per share.

Based on aggregate information from My MarketBeat watchlists, some other companies that HeartBeam investors own include NVIDIA (NVDA), Meta Platforms (META), Bristol Myers Squibb (BMY), Intel (INTC), Micron Technology (MU), PayPal (PYPL) and AbbVie (ABBV).

Company Calendar

Last Earnings
5/13/2025
Today
7/03/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MEDICAL INFO SYS
Sub-Industry
N/A
Current Symbol
NASDAQ:BEAT
Fax
N/A
Employees
1,700
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$8.00
High Stock Price Target
$8.00
Low Stock Price Target
$8.00
Potential Upside/Downside
+545.2%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$19.45 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Book Value
$0.06 per share
Price / Book
20.67

Miscellaneous

Free Float
27,711,000
Market Cap
$41.92 million
Optionable
Not Optionable
Beta
-0.70
5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

This page (NASDAQ:BEAT) was last updated on 7/4/2025 by MarketBeat.com Staff
From Our Partners